Neurocrine Biosciences Presents 48-Week Remission Data On Treatment Of Tardive Dyskinesia With INGREZZA® (Valbenazine) Capsules
Majority of Participants Reached a Defined Threshold for Remission of Tardive Dyskinesia Regardless of Underlying Psychiatric Disorder <l ...
Stocks to Watch Today: Manappuram Finance, Hero MotoCorp, Hindalco, Glenmark, TCS, Lloyds Metals, CDSL, RailTel in focus on 21 March
Stocks like Lloyds Metals and Energy, Ashoka Buildcon, CG Power and Industrial Solutions, Unichem Laboratories, Happiest ...